CytomX Therapeutics Company

CytomX is an Xtraordinary clinical-stage biopharmaceutical company with a unique approach to treating cancer and a team dedicated to make a difference. CytomX has five Probody® programs in the clinic, the goal is to reinvent therapeutic antibodies for the treatment of cancer.
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States

Visit Website
Register and Claim Ownership